NotCo's vegan chicken is now on the menu of two new Burger King sandwiches and nuggets across locations in Chile.
Burger King says the growing demand for vegan options has made the partnership with NotCo, which debuted its vegan chicken last year, an easy decision.
NotCo has previously worked with Burger King on menu items in Chile and Paraguay.
The chicken's launching comes at the same time as Burger King is temporarily eliminating meat from its entire menu at two of its outlets in Chile. It has already been done by the fast food company, most recently in Europe at two sites in Switzerland. That came after its flagship London branch made a vegan change.
Similar to Impossible Foods, Burger King's most notable North American partner, NotCo is gaining consumer brand recognition to boost demand for vegan menu items.
Since NotCo, a Chilean food-tech business known for its Giusseppe AI technology raised $235 million in a Series D fundraising round with contributions from Lewis Hamilton, Roger Federer, and Oscar-winning singer and director Questlove, it's been a busy year.
With the capital from the previous year, NotCo entered the unicorn realm and received a $1.5 billion valuation, a first for a Chilean company. Only a year earlier, the business had a $250 million valuation. Matias Muchnick founded NotCo in 2015 to advance plant-based diets both in its home market of Latin America and throughout the rest of the world.
This spring, NotCo increased its market share in the US by teaming up with Shake Shack to create a dairy-free milkshake. With its NotBurgers, it expanded its influence in Canada as well.
NotCo and Kraft Heinz have created a new joint venture to develop plant-based products.


Microchip Technology Boosts Q3 Outlook on Strong Bookings Momentum
Dollar Slides to Five-Week Low as Asian Stocks Struggle and Markets Bet on Fed Rate Cut
Asian Markets Stabilize as Wall Street Rebounds and Rate Concerns Ease
U.S. Futures Steady as Rate-Cut Bets Rise on Soft Labor Data
Novo Nordisk and Eli Lilly Lower Prices for Weight-Loss Drugs Amid U.S. Agreement
Asian Currencies Edge Higher as Markets Look to Fed Rate Cut; Rupee Steadies Near Record Lows
European Stocks Rise as Markets Await Key U.S. Inflation Data
Europe Confronts Rising Competitive Pressure as China Accelerates Export-Led Growth
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment
Asian Markets Mixed as RBI Cuts Rates and BOJ Signals Possible Hike
Merck Nears Acquisition of Cidara Therapeutics at Significant Premium
Why financial hardship is more likely if you’re disabled or sick
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment
Dollar Weakens Ahead of Expected Federal Reserve Rate Cut
Pfizer Sues Novo Nordisk Over Alleged Tactics to Block Obesity Drug Competition
Pfizer Boosts Bid for Metsera Amid Intensifying Rivalry with Novo Nordisk in Obesity Drug Market 



